Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective

Medicine & Life Sciences

• Kidney Diseases 100%
• Hepatitis C 97%
• Chronic Renal Insufficiency 87%
• Antiviral Agents 81%
• Hepacivirus 58%
• Glomerular Filtration Rate 45%
• Renal Dialysis 41%
• Transplants 39%
• Transplant Recipients 29%
• 2-(pyrrolidin-2-yl)-5-(2-(4-(5-(pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole 28%
• MK-5172 28%
• Kidney 25%
• Transplantation 24%
• Sofosbuvir 23%
• Genotype 22%
• Calcineurin Inhibitors 19%
• Therapeutics 15%
• Drug Interactions 15%
• Viral Load 15%
• Kidney Transplantation 15%
• Interferons 14%
• Dialysis 13%
• Comorbidity 12%
• Hand 12%
• Virus Diseases 11%
• Placebos 10%
• Morbidity 9%
• Mortality 8%
• Infections 7%
• Pharmaceutical Preparations 6%
• Population 6%